Keeping it real by that criteria is keeping the pps at .14.

The company today has more potential for increasing revenues than ever before. They are a proven and recognized entity in the IFE arena, are innovating new products with new partners and are moving the patent efforts through DM forward.

Yet the need to keep it real has some shareholders statisfied with the market's current valuation at .14.

Well, I for one think this company has buckets more potential and value based on the markets the patents cover and the growing IFE market opportunities.

But keep it real....real low.

Yee-hah !

email this chart

printer-friendly format